HRT Financial’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,286
Closed -$142K 3326
2023
Q2
$142K Buy
+11,286
New +$137K ﹤0.01% 1920
2023
Q1
Sell
-16,550
Closed -$291K 3400
2022
Q4
$291K Sell
16,550
-565,193
-97% -$9.47M ﹤0.01% 1740
2022
Q3
$8.86M Buy
581,743
+318,758
+121% +$5.16M 0.1% 159
2022
Q2
$3.9M Buy
262,985
+230,422
+708% +$4.31M 0.04% 323
2022
Q1
$733K Buy
+32,563
New +$660K 0.01% 1338
2021
Q4
Sell
-353,921
Closed -$4.73M 4317
2021
Q3
$4.73M Buy
353,921
+301,236
+572% +$4.86M 0.03% 336
2021
Q2
$975K Sell
52,685
-137,764
-72% -$2.32M 0.01% 1150
2021
Q1
$2.86M Buy
190,449
+116,756
+158% +$1.87M 0.03% 451
2020
Q4
$1.06M Buy
73,693
+8,746
+13% +$106K 0.02% 595
2020
Q3
$528K Buy
+64,947
New +$531K 0.02% 847
2020
Q1
Sell
-57,599
Closed -$565K 1466
2019
Q4
$565K Buy
+57,599
New +$607K 0.02% 492
2019
Q2
Sell
-10,807
Closed -$103K 954
2019
Q1
$103K Buy
+10,807
New +$119K 0.02% 439

Other funds holding MDRX

HRT Financial's MDRX Position: Q3 2023 in Review

HRT Financial sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2023, closing a stake of 11,286 shares — an estimated $142K sold.

HRT Financial first reported a position in MDRX in Q1 2019 and held it in 12 quarters. The position peaked at $8.86M in Q3 2022. 216 funds tracked by Wall St. Rank hold MDRX as of Q3 2023.

  • HRT Financial reported no remaining Veradigm Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 11,286 Veradigm Inc. Common Stock shares in Q3 2023, an estimated $142K.
  • HRT Financial first reported a position in Veradigm Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • HRT Financial's Veradigm Inc. Common Stock position peaked at $8.86M in Q3 2022.
  • 216 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.